These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2191888)

  • 81. Comparison of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with non-insulin-dependent diabetes mellitus.
    Reaven GM; Doberne L; Greenfield MS
    Diabetes; 1982 May; 31(5 Pt 1):382-4. PubMed ID: 6759253
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of acute exercise on insulin binding to monocytes in obesity.
    Koivisto VA; Soman VR; Felig P
    Metabolism; 1980 Feb; 29(2):168-72. PubMed ID: 6986534
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dysfunction of insulin mediator protein kinase FA in lymphocytes of patients with NIDDM.
    Yang SD; Hwang HS; Ha TL; Lai YG; Jean YJ
    Diabetes; 1992 Jan; 41(1):68-75. PubMed ID: 1309356
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients.
    Paolisso G; Sgambato S; Giugliano D; Torella R; Varricchio M; Scheen AJ; D'Onofrio F; Lefèbvre PJ
    Diabetologia; 1988 Dec; 31(12):910-5. PubMed ID: 3071486
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neurotensin in diabetes and obesity.
    Service FJ; Jay JM; Rizza RA; O'Brien PC; Go VL
    Regul Pept; 1986 Mar; 14(1):85-92. PubMed ID: 3715064
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Insulin receptor tyrosine kinase activity is reduced in monocytes from non-obese normoglycaemic insulin-resistant subjects.
    Frittitta L; Grasso G; Munguira ME; Vigneri R; Trischitta V
    Diabetologia; 1993 Nov; 36(11):1163-7. PubMed ID: 8270131
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes.
    Chen MS; Hutchinson ML; Pecoraro RE; Lee WY; Labbé RF
    Diabetes; 1983 Nov; 32(11):1078-81. PubMed ID: 6357907
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Combination therapy with insulin and metformin.
    Hermann LS
    Endocr Pract; 1998; 4(6):404-12. PubMed ID: 15251717
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Normalization of the insulin sensitivity and the cellular insulin binding during treatment of obese diabetics for one year.
    Beck-Nielsen H; Pedersen O; Lindskov HO
    Acta Endocrinol (Copenh); 1979 Jan; 90(1):103-12. PubMed ID: 760352
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Glucose-insulin interaction in obese individuals with asymptomatic reactive hypoglycemia.
    Solter M; Sekso M
    Acta Diabetol Lat; 1979; 16(2):119-27. PubMed ID: 484162
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Insulin binding, internalization, and insulin receptor regulation in fibroblasts from type II, non-insulin-dependent diabetic subjects.
    Prince MJ; Tsai P; Olefsky JM
    Diabetes; 1981 Jul; 30(7):596-600. PubMed ID: 7018965
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Rapid improvement in insulin binding to erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus during therapy.
    Ramachandran A; Susheela L; Mohan V; Kuzhali DA; Viswanathan M
    Acta Diabetol Lat; 1988; 25(3):205-14. PubMed ID: 3149105
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Receptor-mediated endocytosis of insulin: inhibition of [125I]iodoinsulin internalization in insulin resistant diabetic states of man.
    Grunberger G; Geiger D; Carpentier JL; Robert A; Gorden P
    Acta Endocrinol (Copenh); 1989 Oct; 121(4):581-6. PubMed ID: 2678873
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The combination of insulin and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Chaudhuri A; Tomar R; Mohanty P; Szudzik E; Bandyopadhyay A; Arian M; Thusu K; Dandona P
    Endocr Pract; 1998; 4(5):259-67. PubMed ID: 15251721
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Metformin: actions and indications for use in non-insulin-dependent diabetes mellitus.
    Mahler RJ
    Endocr Pract; 1995; 1(6):418-22. PubMed ID: 15251570
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of dietary changes on cellular insulin binding and in vivo insulin sensitivity.
    Beck-Nielsen H; Pedersen O; Sørensen NS
    Metabolism; 1980 May; 29(5):482-7. PubMed ID: 6990183
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Intracellular hydrogen peroxide production by peripheral phagocytes from diabetic patients. Dissociation between polymorphonuclear leucocytes and monocytes.
    Noritake M; Katsura Y; Shinomiya N; Kanatani M; Uwabe Y; Nagata N; Tsuru S
    Clin Exp Immunol; 1992 May; 88(2):269-74. PubMed ID: 1572091
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood.
    Benzi L; Cecchetti P; Ciccarone A; Pilo A; Di Cianni G; Navalesi R
    Diabetes; 1994 Feb; 43(2):297-304. PubMed ID: 8288054
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effects of insulin, glimepiride and combination therapy of insulin and metformin on blood sugar and lipid profile of NIDDM patients.
    Valsaraj S; Augusti KT; Chemmanam V; Jose R
    Indian J Clin Biochem; 2009 Apr; 24(2):175-8. PubMed ID: 23105828
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Altered insulin binding to monocytes and diploid fibroblasts from obese donors.
    Mott DM; Howard BV; Savage PJ; Nagulesparan M
    J Clin Endocrinol Metab; 1983 Jul; 57(1):1-7. PubMed ID: 6343414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.